Telesis Bio Probability of Future Pink Sheet Price Finishing Over 1.7
| TBIODelisted Stock | USD 2.98 0.02 0.67% |
Telesis |
Telesis Bio Target Price Odds to finish over 1.7
The tendency of Telesis Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 1.70 in 90 days |
| 2.98 | 90 days | 1.70 | close to 99 |
Based on a normal probability distribution, the odds of Telesis Bio to stay above $ 1.70 in 90 days from now is close to 99 (This Telesis Bio probability density function shows the probability of Telesis Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Telesis Bio price to stay between $ 1.70 and its current price of $2.98 at the end of the 90-day period is about 23.41 .
Given the investment horizon of 90 days Telesis Bio has a beta of -0.0403. This usually implies as returns on the benchmark increase, returns on holding Telesis Bio are expected to decrease at a much lower rate. During a bear market, however, Telesis Bio is likely to outperform the market. Moreover Telesis Bio has an alpha of 1.3242, implying that it can generate a 1.32 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Telesis Bio Price Density |
| Price |
Predictive Modules for Telesis Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Telesis Bio. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Telesis Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Telesis Bio is not an exception. The market had few large corrections towards the Telesis Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Telesis Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Telesis Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.32 | |
β | Beta against Dow Jones | -0.04 | |
σ | Overall volatility | 0.76 | |
Ir | Information ratio | 0.06 |
Telesis Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Telesis Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Telesis Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Telesis Bio is not yet fully synchronised with the market data | |
| Telesis Bio is way too risky over 90 days horizon | |
| Telesis Bio appears to be risky and price may revert if volatility continues | |
| Telesis Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 27.51 M. Net Loss for the year was (47.72 M) with profit before overhead, payroll, taxes, and interest of 15.6 M. | |
| Telesis Bio currently holds about 654.75 M in cash with (34.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company outstanding shares are owned by corporate insiders |
Telesis Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Telesis Pink Sheet often depends not only on the future outlook of the current and potential Telesis Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Telesis Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.8 M | |
| Cash And Short Term Investments | 19.3 M |
Telesis Bio Technical Analysis
Telesis Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Telesis Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Telesis Bio. In general, you should focus on analyzing Telesis Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Telesis Bio Predictive Forecast Models
Telesis Bio's time-series forecasting models is one of many Telesis Bio's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Telesis Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Telesis Bio
Checking the ongoing alerts about Telesis Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Telesis Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Telesis Bio is not yet fully synchronised with the market data | |
| Telesis Bio is way too risky over 90 days horizon | |
| Telesis Bio appears to be risky and price may revert if volatility continues | |
| Telesis Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 27.51 M. Net Loss for the year was (47.72 M) with profit before overhead, payroll, taxes, and interest of 15.6 M. | |
| Telesis Bio currently holds about 654.75 M in cash with (34.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company outstanding shares are owned by corporate insiders |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |